1. Home
  2. BUSE vs AXGN Comparison

BUSE vs AXGN Comparison

Compare BUSE & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Busey Corporation

BUSE

First Busey Corporation

HOLD

Current Price

$27.05

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$40.92

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUSE
AXGN
Founded
1868
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
BUSE
AXGN
Price
$27.05
$40.92
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$27.17
$42.33
AVG Volume (30 Days)
467.1K
863.7K
Earning Date
04-28-2026
04-28-2026
Dividend Yield
4.04%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$719,584,000.00
$225,208,000.00
Revenue This Year
$23.84
$20.57
Revenue Next Year
$3.82
$16.68
P/E Ratio
$52.01
N/A
Revenue Growth
55.66
20.21
52 Week Low
$21.63
$9.22
52 Week High
$27.65
$45.83

Technical Indicators

Market Signals
Indicator
BUSE
AXGN
Relative Strength Index (RSI) 59.87 53.56
Support Level $25.69 $39.52
Resistance Level $27.11 $45.14
Average True Range (ATR) 0.47 1.59
MACD 0.05 -0.38
Stochastic Oscillator 93.85 28.37

Price Performance

Historical Comparison
BUSE
AXGN

About BUSE First Busey Corporation

First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: